David Irvin

445 total citations
7 papers, 279 citations indexed

About

David Irvin is a scholar working on Genetics, Molecular Biology and Immunology. According to data from OpenAlex, David Irvin has authored 7 papers receiving a total of 279 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Genetics, 3 papers in Molecular Biology and 2 papers in Immunology. Recurrent topics in David Irvin's work include Glioma Diagnosis and Treatment (5 papers), Immune cells in cancer (2 papers) and Nanoplatforms for cancer theranostics (2 papers). David Irvin is often cited by papers focused on Glioma Diagnosis and Treatment (5 papers), Immune cells in cancer (2 papers) and Nanoplatforms for cancer theranostics (2 papers). David Irvin collaborates with scholars based in United States and Germany. David Irvin's co-authors include Ryan Bash, C. Ryan Miller, Juli R. Bagó, Shawn Hingtgen, Ralf S. Schmid, Robert S. McNeill, Matthew G. Ewend, Yu-Ting Su, H. Shelton Earp and Lin Xiao and has published in prestigious journals such as Nature Communications, PLoS ONE and Neuro-Oncology.

In The Last Decade

David Irvin

7 papers receiving 278 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David Irvin United States	6	107	103	100	78	49	7	279
Sophie Guelfi France	8	74 0.7×	157 1.5×	59 0.6×	79 1.0×	90 1.8×	10	317
Jack Shireman United States	12	178 1.7×	197 1.9×	93 0.9×	86 1.1×	89 1.8×	24	403
Tobias Bergström Sweden	10	119 1.1×	176 1.7×	68 0.7×	71 0.9×	55 1.1×	17	355
Stephen V. Carney United States	8	168 1.6×	146 1.4×	63 0.6×	68 0.9×	61 1.2×	12	310
Jessica Tomé-García United States	10	104 1.0×	178 1.7×	36 0.4×	100 1.3×	60 1.2×	17	342
Wiaam Badn Sweden	10	147 1.4×	89 0.9×	156 1.6×	52 0.7×	164 3.3×	12	351
Ashley Aaroe United States	6	96 0.9×	84 0.8×	63 0.6×	41 0.5×	80 1.6×	17	321
Fangling Cheng China	9	87 0.8×	153 1.5×	63 0.6×	96 1.2×	68 1.4×	18	339
Shivani Baisiwala United States	8	122 1.1×	145 1.4×	38 0.4×	70 0.9×	57 1.2×	14	264
Christin Schmidt Germany	7	150 1.4×	175 1.7×	123 1.2×	89 1.1×	62 1.3×	12	382

Countries citing papers authored by David Irvin

Since Specialization

Citations

This map shows the geographic impact of David Irvin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Irvin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Irvin more than expected).

Fields of papers citing papers by David Irvin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Irvin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Irvin. The network helps show where David Irvin may publish in the future.

Co-authorship network of co-authors of David Irvin

This figure shows the co-authorship network connecting the top 25 collaborators of David Irvin. A scholar is included among the top collaborators of David Irvin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Irvin. David Irvin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Irvin, David, Juli R. Bagó, Kevin Sheets, et al.. (2018). Intra-cavity stem cell therapy inhibits tumor progression in a novel murine model of medulloblastoma surgical resection. PLoS ONE. 13(7). e0198596–e0198596. 10 indexed citations

2.

Vitucci, Mark, David Irvin, Robert S. McNeill, et al.. (2017). Genomic profiles of low-grade murine gliomas evolve during progression to glioblastoma. Neuro-Oncology. 19(9). 1237–1247. 15 indexed citations

3.

Wu, Jing, Ryan Bash, Stephanie M. Cohen, et al.. (2017). MerTK as a therapeutic target in glioblastoma. Neuro-Oncology. 20(1). 92–102. 66 indexed citations

4.

Bagó, Juli R., Ralf S. Schmid, David Irvin, et al.. (2016). Reactive astrocytes potentiate tumor aggressiveness in a murine glioma resection and recurrence model. Neuro-Oncology. 18(12). 1622–1633. 97 indexed citations

5.

Irvin, David, Robert S. McNeill, Ryan Bash, & C. Ryan Miller. (2016). Intrinsic Astrocyte Heterogeneity Influences Tumor Growth in Glioma Mouse Models. Brain Pathology. 27(1). 36–50. 32 indexed citations

6.

Bagó, Juli R., Ralf S. Schmid, David Irvin, et al.. (2016). TMOD-34. REACTIVE ASTROCYTES POTENTIATE TUMOR AGGRESSIVENESS IN A MURINE GLIOMA RESECTION AND RECURRENCE MODEL. Neuro-Oncology. 18(suppl_6). vi214–vi214. 1 indexed citations

7.

Dunleavey, James M., Lin Xiao, Joshua J. Thompson, et al.. (2014). Vascular channels formed by subpopulations of PECAM1+ melanoma cells. Nature Communications. 5(1). 5200–5200. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact